Burned by Fortinet, Inc.? Contact Levi & Korsinsky to SueWallSt And Fight Back

NEW YORK, NY / ACCESS Newswire / November 10, 2025 / – SueWallSt: Class Action Filed Against Fortinet, Inc. – Contact Levi & Korsinsky A Class Action lawsuit was filed on behalf of investors who lost money as a result of alleged securities fraud between November 8, 2024 and August 6, 2025. If you suffered […]

Pomerantz LLP Alerts Shareholders to Investor Suit Involving Avantor, Inc. – AVTR

NEW YORK CITY, NY / ACCESS Newswire / November 10, 2025 / Pomerantz LLP announces that a class action lawsuit has been filed against Avantor, Inc. ("Avantor" or the "Company") (NYSE:AVTR). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged

Class Action Lodged by Pomerantz LLP Versus Lantheus Holdings, Inc. – LNTH

NEW YORK CITY, NY / ACCESS Newswire / November 10, 2025 / Pomerantz LLP announces that a class action lawsuit has been filed against Lantheus Holdings, Inc. ("Lantheus" or the "Company") (NASDAQ:LNTH). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are

Deadline Approaching for Cytokinetics, Incorporated (CYTK) Shareholders with $100k+ in Losses: Kahn Swick & Foti, LLC Leads Class Action Lawsuit

NEW YORK CITY, NY AND NEW ORLEANS, LA, LA / ACCESS Newswire / November 10, 2025 / Kahn Swick & Foti, LLC ("KSF") and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have until November 17, 2025 to file lead plaintiff applications in a securities class action lawsuit

Onward Therapeutics Completes Share Exchange and Establishes Global Headquarters in Taiwan

— Following the group restructuring, Onward Therapeutics, Inc. serves as the global headquarters and holding company in Taiwan. — The existing Swiss and French subsidiaries maintain fully operational, focusing on preclinical and clinical development. — All licenses, IP rights, and ongoing R&D projects remain unchanged. Onward Therapeutics today announced the completion of a share exchange,

Singapore Businesses Go Global: One in Four Sell Internationally with PayPal

— Top 3 industry verticals fueling Singapore's cross-border growth are gaming, beauty, and fashion, which generated over US$1.6B1 in transaction value. — Beyond the U.S., Singapore businesses are capturing new consumer demand in Mexico, where shoppers are turning to Singapore for beauty and fashion products. More than 90,000 Singapore-based businesses are selling internationally withPayPal. This

Class Action Lodged by Pomerantz LLP Concerning Fluor Corporation – FLR

NEW YORK CITY, NY / ACCESS Newswire / November 10, 2025 / Pomerantz LLP announces that a class action lawsuit has been filed against Fluor Corporation ("Fluor" or the "Company") (NYSE:FLR) and certain officers.�� The class action, filed in the United States District Court for the Northern District of Texas, Dallas Division, and docketed under

Pomerantz LLP Reminds Affected Investors of Class Action Timeline for Fluor Corporation – FLR

NEW YORK CITY, NY / ACCESS Newswire / November 10, 2025 / Pomerantz LLP announces that a class action lawsuit has been filed against Fluor Corporation ("Fluor" or the "Company") (NYSE:FLR) and certain officers.�� The class action, filed in the United States District Court for the Northern District of Texas, Dallas Division, and docketed under

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Jefferies Financial Group Inc. – JEF

NEW YORK CITY, NY / ACCESS Newswire / November 10, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Jefferies Financial Group Inc. ("Jefferies" or the "Company") (NYSE:JEF). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Jefferies and certain of its officers

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Exelixis, Inc. – EXEL

NEW YORK CITY, NY / ACCESS Newswire / November 10, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Exelixis, Inc. ("Exelixis" or the "Company") (NASDAQ:EXEL). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Exelixis and certain of its officers and/or directors

Scroll to Top